Comparison of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention in Patients with Diabetes

被引：3

作者：

Toklu B. ^{[1
]}

Bangalore S. ^{[1
,2
]}

机构：

[1] New York University School of Medicine, New York, 10016, NY

[2] Cardiac Catheterization Laboratory, Cardiovascular Clinical Research Center, The Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, 10016, NY

来源：

Current Treatment Options in Cardiovascular Medicine | 2015年 / 17卷 / 5期

关键词：

Coronary artery bypass graft; Coronary artery disease; Diabetes mellitus; Drug-eluting stents;

D O I：

10.1007/s11936-015-0377-y

中图分类号：

学科分类号：

摘要：

The optimal revascularization strategy in patients with diabetes is controversial. The Bypass Angioplasty Revascularization Investigation (BARI) trial, done more than a decade ago, suggested a mortality benefit of coronary artery bypass graft surgery (CABG) when compared with percutaneous coronary intervention (PCI) (with plain old balloon angioplasty) in the subgroup of patients with diabetes. In addition, several observational studies and meta-analyses similarly suggest a benefit of CABG over PCI in patients with diabetes. However, most of these studies compared CABG with PCI using balloon angioplasty, bare metal stents, or first-generation drug-eluting stents. In this review, we critically examine the data for optimal revascularization strategy in patients with diabetes and ask the question whether the currently available data from randomized trials that used outdated stents are applicable to current day practice. © 2015, Springer Science+Business Media New York.

引用

页数：13

共 66 条

[1]

Abdallah M.S., Wang K., Magnuson E.A., Et al., Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial, JAMA, 310, 15, pp. 1581-1590, (2013)

[2]

AuthorsTask Force M., Windecker S., Kolh P., Et al., ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, 35, 37, pp. 2541-2619, (2014)

[3]

Bangalore S., Kumar S., Fusaro M., Et al., Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials, BMJ, 345, (2012)

[4]

Bangalore S., Toklu B., Amoroso N., Et al., Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis, BMJ, 347, (2013)

[5]

Bangalore S., Toklu B., Feit F., Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap? Circulation, Cardiovasc Interv, 7, 4, pp. 518-525, (2014)

[6]

Banning A.P., Westaby S., Morice M.C., Et al., Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents, J Am Coll Cardiol, 55, 11, pp. 1067-1075, (2010)

[7]

Bayes-Genis A., Conover C.A., Schwartz R.S., The insulin-like growth factor axis: a review of atherosclerosis and restenosis, Circ Res, 86, 2, pp. 125-130, (2000)

[8]

Biondi-Zoccai G.G., Abbate A., Liuzzo G., Biasucci L.M., Atherothrombosis, inflammation, and diabetes, J Am Coll Cardiol, 41, 7, pp. 1071-1077, (2003)

[9]

Booth J., Clayton T., Pepper J., Et al., Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS), Circulation, 118, 4, pp. 381-388, (2008)

[10]

Brar S.S., Syros G., Dangas G., Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications, Angiology, 59, pp. 83-88, (2008)

← 1 2 3 4 5 6 7 →